Zelanna Goldberg

2021

In 2021, Zelanna Goldberg earned a total compensation of $1.7M as Former Chief Medical Officer at Nivalis Therapeutics.

Compensation breakdown

Option Awards$1,140,770
Salary$180,912
Other$365,181
Total$1,686,863

Goldberg received $1.1M in option awards, accounting for 68% of the total pay in 2021.

Goldberg also received $180.9K in salary and $365.2K in other compensation.

Rankings

In 2021, Zelanna Goldberg's compensation ranked 6,745th out of 12,415 executives tracked by ExecPay. In other words, Goldberg earned more than 45.7% of executives.

ClassificationRankingPercentile
All
6,745
out of 12,415
46th
Division
Manufacturing
2,926
out of 5,505
47th
Major group
Chemicals And Allied Products
1,291
out of 2,375
46th
Industry group
Drugs
1,150
out of 2,096
45th
Industry
Pharmaceutical Preparations
839
out of 1,546
46th
Source: SEC filing on April 29, 2022.

Goldberg's colleagues

We found three more compensation records of executives who worked with Zelanna Goldberg at Nivalis Therapeutics in 2021.

2021

Mitchell Gold

Nivalis Therapeutics

Chief Executive Officer

2021

Stanford Peng

Nivalis Therapeutics

President and Head of Research and Development

2021

Paul Rickey

Nivalis Therapeutics

Chief Financial Officer

News

In-depth

You may also like